308 related articles for article (PubMed ID: 9790108)
21. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
[TBL] [Abstract][Full Text] [Related]
22. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
Aubele M; Auer G; Jütting U; Falkmer U; Gais P
Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
[TBL] [Abstract][Full Text] [Related]
24. Proliferative activity in the malignant cellular blue nevus.
Pich A; Chiusa L; Margaria E; Aloi F
Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of argyrophilic nucleolar organizer region (AgNOR) staining in feline intestinal lymphoma.
Rassnick KM; Mauldin GN; Moroff SD; Mauldin GE; McEntee MC; Mooney SC
J Vet Intern Med; 1999; 13(3):187-90. PubMed ID: 10357106
[TBL] [Abstract][Full Text] [Related]
26. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of argyrophilic nucleolar organizer regions in nasopharyngeal carcinoma.
Pak MW; To KF; Leung SF; van Hasselt CA
Eur Arch Otorhinolaryngol; 2000 Nov; 257(9):517-20. PubMed ID: 11131381
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of argyrophilic nucleolar organizer staining for predicting prognosis of patients with recurrent soft tissue sarcoma.
Kuratsu S; Ohsawa M; Naka N; Myoui A; Tomita Y; Uchida A; Ono K; Aozasa K
Oncology; 1994; 51(3):244-50. PubMed ID: 8196907
[TBL] [Abstract][Full Text] [Related]
29. [Value of nucleolus organizer regions (AgNORs) in dermatologic oncology].
Pfau A; Eckert F; Schröpfer T; Rüschoff J
Hautarzt; 1994 Nov; 45(11):762-8. PubMed ID: 7822200
[TBL] [Abstract][Full Text] [Related]
30. Argyrophilic nucleolar organizer regions: their value and correlation with clinical prognostic factors in breast carcinoma.
Kumar A; Kushwaha AK; Kumar M; Gupta S
J Surg Oncol; 1997 Jul; 65(3):201-4. PubMed ID: 9236930
[TBL] [Abstract][Full Text] [Related]
31. Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology.
Plate KH; Rüschoff J; Mennel HD
Neuropathol Appl Neurobiol; 1991 Apr; 17(2):121-32. PubMed ID: 1713308
[TBL] [Abstract][Full Text] [Related]
32. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
33. Argyrophilic nucleolar organizer regions in Wilms' tumors and related lesions: a histologic and chromosomal correlation.
Mourad WA; Lavallee-Grey M; Pappenhausen P; Essig YP; Rowlands DT
Mod Pathol; 1991 Mar; 4(2):247-52. PubMed ID: 1646458
[TBL] [Abstract][Full Text] [Related]
34. AgNOR counts have no prognostic value in breast cancer.
Toikkanen S; Joensuu H
J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490
[TBL] [Abstract][Full Text] [Related]
35. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
36. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
Simha M; Menon M; Doctor V
Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
[TBL] [Abstract][Full Text] [Related]
38. Argyrophilic nuclear organizer regions (AgNORs) in pediatric acute lymphoblastic leukemia.
Sreelekha TT; Kusumakumary P; Srinivas G; Kumar SR; Pushpakumary S; Nair MK; Pillai MR
Cancer Lett; 1996 Nov; 108(1):87-91. PubMed ID: 8950214
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients.
Pich A; Chiusa L; Audisio E; Marmont F
J Clin Oncol; 1998 Apr; 16(4):1512-8. PubMed ID: 9552060
[TBL] [Abstract][Full Text] [Related]
40. Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors.
Khanna AK; Giri AK; Khanna A; Kumar M
J Surg Oncol; 2001 Dec; 78(4):273-8. PubMed ID: 11745824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
